Rochester, Minn.-based Mayo Clinic developed an artificial intelligence model using electrocardiogram data that outperformed the current model for ...
1d
Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal Intervention Symposium
The alfa pump® system received U.S. FDA Premarket Approval in December 2024 for the treatment of recurrent or refractory ascites due to liver cirrhosis. It is the first active implantable medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback